Valuation: CHF Solutions Inc

Market Cap 4.48M 3.88M 3.63M 3.31M 6.23M 427M 6.33M 42.74M 16.71M 214M 16.81M 16.44M 713M P/E 2024 *
-
P/E 2025 -0.07x
Enterprise Value 3.72M 3.22M 3.02M 2.75M 5.18M 355M 5.26M 35.52M 13.88M 178M 13.97M 13.66M 592M EV / Sales 2024
-0.06x
EV / Sales 2025 0.26x
Free-Float
170.32%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 64 2026-06-29
Director of Finance/CFO 48 2026-02-01
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 76 2011-08-02
Chairman 77 2012-09-30
Director/Board Member 63 2023-10-31
Change 5-day change 1-year change 3-year change Capi.($)
+9.86%-30.94% - - 4.48M
-0.33%+4.36%+26.31%+10.89% 223B
-0.80%+3.07%+0.03%-19.43% 145B
+0.01%+6.95%-16.09%+31.78% 142B
+0.45%+7.71%-49.90%+0.76% 74.52B
-0.65%+4.59%+20.95%+17.18% 53.63B
-1.41%-0.54%-15.65%-17.29% 50.14B
-0.84%+5.05%+26.36%+16.85% 41.87B
+0.28%+4.04%+45.75%+42.68% 40.89B
-0.65%+2.90%-2.86%+0.96% 32.65B
Average +0.75%+4.23%+3.88%+9.38% 89.23B
Weighted average by Cap. -0.27%+4.56%+3.85%+8.36%

Financials

2024 2025
Net sales 8.74M 7.57M 7.09M 6.47M 12.17M 834M 12.35M 83.45M 32.62M 417M 32.82M 32.1M 1.39B 8.27M 7.17M 6.71M 6.12M 11.51M 789M 11.69M 78.96M 30.86M 395M 31.05M 30.38M 1.32B
Net income -11.16M -9.67M -9.06M -8.27M -15.54M -1.06B -15.78M -107M -41.67M -533M -41.92M -41.01M -1.78B -17.52M -15.18M -14.22M -12.97M -24.39M -1.67B -24.76M -167M -65.39M -837M -65.78M -64.35M -2.79B
Net Debt -4.55M -3.94M -3.69M -3.37M -6.33M -434M -6.43M -43.44M -16.98M -217M -17.08M -16.71M -725M -757K -656K -615K -560K -1.05M -72.2M -1.07M -7.23M -2.83M -36.15M -2.84M -2.78M -121M
Logo CHF Solutions Inc
Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Employees
-